{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:23:00Z","timestamp":1784067780813,"version":"3.55.0"},"reference-count":40,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Deutsche Forschungsgemeinschaft","award":["158989968"],"award-info":[{"award-number":["158989968"]}]},{"name":"Deutsche Forschungsgemeinschaft","award":["SFB900"],"award-info":[{"award-number":["SFB900"]}]},{"name":"Deutsche Forschungsgemeinschaft","award":["SFB738"],"award-info":[{"award-number":["SFB738"]}]},{"name":"Deutsche Forschungsgemeinschaft","award":["DS354"],"award-info":[{"award-number":["DS354"]}]},{"DOI":"10.13039\/501100010621","name":"Medical University of Lublin","doi-asserted-by":"publisher","award":["158989968"],"award-info":[{"award-number":["158989968"]}],"id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010621","name":"Medical University of Lublin","doi-asserted-by":"publisher","award":["SFB900"],"award-info":[{"award-number":["SFB900"]}],"id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010621","name":"Medical University of Lublin","doi-asserted-by":"publisher","award":["SFB738"],"award-info":[{"award-number":["SFB738"]}],"id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010621","name":"Medical University of Lublin","doi-asserted-by":"publisher","award":["DS354"],"award-info":[{"award-number":["DS354"]}],"id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"publisher"}]},{"name":"German Centre for Infection Research (DZIF)","award":["158989968"],"award-info":[{"award-number":["158989968"]}]},{"name":"German Centre for Infection Research (DZIF)","award":["SFB900"],"award-info":[{"award-number":["SFB900"]}]},{"name":"German Centre for Infection Research (DZIF)","award":["SFB738"],"award-info":[{"award-number":["SFB738"]}]},{"name":"German Centre for Infection Research (DZIF)","award":["DS354"],"award-info":[{"award-number":["DS354"]}]},{"name":"University of Duisburg-Essen","award":["158989968"],"award-info":[{"award-number":["158989968"]}]},{"name":"University of Duisburg-Essen","award":["SFB900"],"award-info":[{"award-number":["SFB900"]}]},{"name":"University of Duisburg-Essen","award":["SFB738"],"award-info":[{"award-number":["SFB738"]}]},{"name":"University of Duisburg-Essen","award":["DS354"],"award-info":[{"award-number":["DS354"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Hepatitis C virus (HCV) infection is closely associated with lipid metabolism defects along with a high prevalence of hepatic steatosis. After HCV clearance, steatosis persists in many patients. However, the reasons behind this phenomenon are not completely clear. To investigate the association between 92 soluble inflammatory mediators (SIMs) and the steatosis grade, we made use of a cohort of 94 patients with chronic HCV infection who cleared HCV after direct-acting antiviral agent (DAA) treatment. Patients were classified into three groups according to their controlled attenuation parameter (CAP). CAP is associated with ALT, \u03b3-GT and liver stiffness after HCV clearance. While stem cell factor (SCF) and tumor necrosis factor ligand superfamily member 12 (TWEAK) levels were significantly reduced in patients with CAP &gt; 299 dB\/m, the levels of fibroblast growth factor (FGF)-21 and interleukin-18 receptor 1 (IL-18R1) were higher in those patients at week 96 after virus clearance. These four markers also showed a linear correlation with CAP values. FGF-21 levels correlated with CAP only after HCV clearance. Taken together, these four biomarkers, namely SCF, TWEAK, FGF-21 and IL-18R1, are associated with CAP status after virus clearance. A potential role of these proteins in the pathogenesis of post-sustained viral response (SVR) nonalcoholic steatohepatitis requires further investigation.<\/jats:p>","DOI":"10.3390\/biomedicines11061529","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T01:52:43Z","timestamp":1685065963000},"page":"1529","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Controlled Attenuation Parameter Is Associated with a Distinct Systemic Inflammatory Milieu after Clearance of HCV Infection"],"prefix":"10.3390","volume":"11","author":[{"given":"Yanqin","family":"Du","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany"},{"name":"Department of Infectious Diseases, Union Hospital, Tongji Medical School, Huazhong University of Science and Technology, Wuhan 430022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanvi","family":"Khera","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany"},{"name":"Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, 30625 Hannover, Germany"},{"name":"International AIDS Vaccine Initiative (IAVI), 122002 Gurugram, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoli","family":"Liu","sequence":"additional","affiliation":[{"name":"Centre for Individualized Infection Medicine (CiiM), a Joint Venture between the Helmholtz Centre for Infection Research (HZI) and Hannover Medical School (MHH), 30625 Hannover, Germany"},{"name":"TWINCORE Centre for Experimental and Clinical Infection Research, a Joint Venture between the Helmholtz Centre for Infection Research (HZI) and the Hannover Medical School (MHH), 30625 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5640-5432","authenticated-orcid":false,"given":"Magdalena","family":"Tudrujek-Zdunek","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Medical University of Lublin, 20-081 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dworzanska","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Medical University of Lublin, 20-081 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Cornberg","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, 30625 Hannover, Germany"},{"name":"TWINCORE Centre for Experimental and Clinical Infection Research, a Joint Venture between the Helmholtz Centre for Infection Research (HZI) and the Hannover Medical School (MHH), 30625 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1586-4672","authenticated-orcid":false,"given":"Cheng-Jian","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, 30625 Hannover, Germany"},{"name":"Centre for Individualized Infection Medicine (CiiM), a Joint Venture between the Helmholtz Centre for Infection Research (HZI) and Hannover Medical School (MHH), 30625 Hannover, Germany"},{"name":"TWINCORE Centre for Experimental and Clinical Infection Research, a Joint Venture between the Helmholtz Centre for Infection Research (HZI) and the Hannover Medical School (MHH), 30625 Hannover, Germany"},{"name":"Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Tomasiewicz","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Medical University of Lublin, 20-081 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiner","family":"Wedemeyer","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany"},{"name":"Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, 30625 Hannover, Germany"},{"name":"Excellence Cluster Resist, Hannover Medical School, 30625 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2019.03.004","article-title":"Global liver disease burdens and research trends: Analysis from a Chinese perspective","volume":"71","author":"Xiao","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nrgastro.2013.171","article-title":"The global NAFLD epidemic","volume":"10","author":"Loomba","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016\u20132030","volume":"69","author":"Estes","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jiph.2019.11.015","article-title":"Overview of hepatitis C infection, molecular biology, and new treatment","volume":"13","author":"Rabaan","year":"2020","journal-title":"J. Infect. Public Health"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/jvh.12035","article-title":"Hepatitis C virus diversity and hepatic steatosis","volume":"20","author":"Roingeard","year":"2013","journal-title":"J. Viral Hepat."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1053\/j.gastro.2003.11.020","article-title":"Steatosis and hepatitis C virus: Mechanisms and significance for hepatic and extrahepatic disease","volume":"126","author":"Lonardo","year":"2004","journal-title":"Gastroenterology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1872-034X.2010.00626.x","article-title":"The importance of steatosis in chronic hepatitis C infection and its management: A review","volume":"40","author":"Cross","year":"2010","journal-title":"Hepatol. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/gut.2002.009936","article-title":"Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: Indirect evidence of a role of hepatitis C virus genotype 3 in steatosis","volume":"53","author":"Castera","year":"2004","journal-title":"Gut"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/liv.14186","article-title":"Baseline risk factors determine lack of biochemical response after SVR in chronic hepatitis C patients treated with DAAs","volume":"40","author":"Tacke","year":"2020","journal-title":"Liver Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jhep.2013.12.018","article-title":"Controlled attenuation parameter (CAP) for the diagnosis of steatosis: A prospective study of 5323 examinations","volume":"60","author":"Vergniol","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1148\/radiol.2017162931","article-title":"MR spectroscopy-derived proton density fat fraction is superior to controlled attenuation parameter for detecting and grading hepatic steatosis","volume":"286","author":"Runge","year":"2018","journal-title":"Radiology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/liv.12282","article-title":"Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: A prospective study of a native Korean population","volume":"34","author":"Chon","year":"2014","journal-title":"Liver Int."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/jmv.24950","article-title":"Serial changes in liver stiffness and controlled attenuation parameter following direct-acting antiviral therapy against hepatitis C virus genotype 1b","volume":"90","author":"Ogasawara","year":"2018","journal-title":"J. Med. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/jvh.13050","article-title":"Role of soluble inflammatory mediators and different immune cell populations in early control of symptomatic acute hepatitis C virus infection","volume":"26","author":"Hengst","year":"2019","journal-title":"J. Viral Hepat."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/hep.26901","article-title":"The ABCs of viral hepatitis that define biomarker signatures of acute viral hepatitis","volume":"59","author":"Duffy","year":"2014","journal-title":"Hepatology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/hep.27971","article-title":"Temporal dynamics of inflammatory cytokines\/chemokines during sofosbuvir and ribavirin therapy for genotype 2 and 3 hepatitis C infection","volume":"62","author":"Carlin","year":"2015","journal-title":"Hepatology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1093\/infdis\/jiw457","article-title":"Direct-Acting Antiviral-Induced hepatitis c virus clearance does not completely restore the altered cytokine and chemokine milieu in patients with chronic hepatitis c","volume":"214","author":"Hengst","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/infdis\/jiab048","article-title":"Long-Lasting imprint in the soluble inflammatory milieu despite early treatment of acute symptomatic hepatitis c","volume":"226","author":"Khera","year":"2022","journal-title":"J. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Schlevogt, B., Boeker, K., Mauss, S., Klinker, H., Heyne, R., Link, R., Simon, K.-G., Sarrazin, C., Serfert, Y., and Manns, M.P. (2021). Weight Gain after Interferon-Free Treatment of Chronic Hepatitis C-Results from the German Hepatitis C-Registry (DHC-R). Biomedicines, 9.","DOI":"10.3390\/biomedicines9101495"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/jdi.12869","article-title":"Soluble CD163 correlates with lipid metabolic adaptations in type 1 diabetes patients during ketoacidosis","volume":"10","author":"Svart","year":"2019","journal-title":"J. Diabetes Investig."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3748\/wjg.v18.i8.727","article-title":"Role of cytokines and chemokines in non-alcoholic fatty liver disease","volume":"18","author":"Braunersreuther","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/apt.14554","article-title":"Viral eradication reduces both liver stiffness and steatosis in patients with chronic hepatitis C virus infection who received direct-acting anti-viral therapy","volume":"47","author":"Tada","year":"2018","journal-title":"Aliment. Pharm. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Oeda, S., Tanaka, K., Oshima, A., Matsumoto, Y., Sueoka, E., and Takahashi, H. (2020). Diagnostic accuracy of FibroScan and factors affecting measurements. Diagnostics, 10.","DOI":"10.3390\/diagnostics10110940"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2174\/1871530321666210125125500","article-title":"The Effect of HCV Eradication after Direct-Acting Antiviral Agents on Hepatic Steatosis: A Prospective Observational Study","volume":"22","author":"Soliman","year":"2022","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/gut.2005.069757","article-title":"Steatosis in chronic hepatitis C: Why does it really matter?","volume":"55","author":"Asselah","year":"2006","journal-title":"Gut"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0168-8278(03)00463-X","article-title":"In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: Implications for therapy","volume":"39","author":"Hickman","year":"2003","journal-title":"J. Hepatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.2169\/internalmedicine.1514-18","article-title":"Carotid intima-media thickness and small dense low-density lipoprotein cholesterol increase after one year of treatment with direct-acting antivirals in patients with hepatitis c virus infection","volume":"58","author":"Ichikawa","year":"2019","journal-title":"Intern. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/ijo.2016.73","article-title":"Reduced circulating levels of sTWEAK are associated with NAFLD and may affect hepatocyte triglyceride accumulation","volume":"40","author":"Llaurado","year":"2016","journal-title":"Int. J. Obes. (Lond.)"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41374-021-00680-9","article-title":"Hepatocyte-specific fibroblast growth factor 21 overexpression ameliorates high-fat diet-induced obesity and liver steatosis in mice","volume":"102","author":"Yano","year":"2022","journal-title":"Lab. Investig."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1186\/ar3295","article-title":"Soluble interleukin-18 receptor complex is a novel biomarker in rheumatoid arthritis","volume":"13","author":"Takei","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1089\/aid.2020.0177","article-title":"Pro-Inflammatory interleukin-18 is associated with hepatic steatosis and elevated liver enzymes in people with HIV monoinfection","volume":"37","author":"Sim","year":"2021","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"ref_33","first-page":"3870454","article-title":"Predictive role of interleukin-18 in liver steatosis in obese children","volume":"2018","author":"Tarasow","year":"2018","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00441-016-2429-3","article-title":"Role of stem cell factor in the placental niche","volume":"366","author":"Khodadi","year":"2016","journal-title":"Cell Tissue Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/08977190600560636","article-title":"Implication of stem cell factor in human liver regeneration after transplantation and resection","volume":"24","author":"Baccarani","year":"2006","journal-title":"Growth Factors"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Allaire, M., and Gilgenkrantz, H. (2018). The impact of steatosis on liver regeneration. Horm. Mol. Biol. Clin. Investig., 41.","DOI":"10.1515\/hmbci-2018-0050"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1053\/j.gastro.2010.04.054","article-title":"Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease","volume":"139","author":"Dushay","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1210\/jc.2013-1848","article-title":"Serum sTWEAK concentrations and risk of developing type 2 diabetes in a high cardiovascular risk population: A nested case-control study","volume":"98","author":"Chacon","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.atherosclerosis.2007.10.022","article-title":"Serum levels of the atherosclerosis biomarker sTWEAK are decreased in type 2 diabetes and end-stage renal disease","volume":"199","author":"Kralisch","year":"2008","journal-title":"Atherosclerosis"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1475-2840-13-51","article-title":"Reduced circulating sTWEAK levels are associated with metabolic syndrome in elderly individuals at high cardiovascular risk","volume":"13","author":"Bullo","year":"2014","journal-title":"Cardiovasc. Diabetol."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/11\/6\/1529\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:42:02Z","timestamp":1760125322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/11\/6\/1529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,25]]},"references-count":40,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["biomedicines11061529"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines11061529","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,25]]}}}